Webb20 maj 2024 · More recently, Theraflex® (MacoPharma, Mouvaux, France) has been developed as a third option, and uses short wavelength UVC (254 nm) without any added photosensitizer. The successful application of this approach has been highly anticipated because of its simple procedure, and a phase III clinical trial is currently under way [ 18 ]. WebbBackground: A novel short-wave ultraviolet light (UVC) pathogen reduction technology (THERAFLEX UV-Platelets; MacoPharma, Mouvaux, France) without the need of any …
TheraFlex™ - TheraFlex V2 Performance Knee & Leg Compression …
Webbultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method P. Sandgren,1 F. Tolksdorf,2 W. G. Struff2 & H. Gulliksson1 1Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden 2MacoPharma International GmbH, Langen, … WebbPresently the THERAFLEX UV-Platelets system is the simplest and purest PIT easily adaptable to the existing blood bank setting. In the future, extension of the application … on to you consignment fort collins
Characteristics of the THERAFLEX UV-Platelets pathogen …
WebbEvery step of the way, we have enabled our customers to collect, process, store and distribute blood components that meet the highest safety and quality standards for patient transfusion. Collection Separation Leukoreduction … WebbResults: THERAFLEX UV-Platelets reduced HAV titers in PCs to the limit of detection, resulting in a virus reduction factor of greater than 4.2 log steps, and reduced FCV … WebbCurrently, more than 1080 peer-reviewed papers are displayed on PubMed when initiating a search for therapeutic indications and mechanisms of action of extracorporeal photochemotherapy (ECP). on to you 意味